Literature DB >> 22883359

Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) in vital primary molar pulpotomy.

E Yaman1, F Görken, A Pinar Erdem, E Sepet, Z Aytepe.   

Abstract

AIM: To compare the clinical and radiographic success rates of two vital pulpotomy agents: formocresol (FC) and Ankaferd Blood Stopper(®) (ABS), in primary molars during a 12-month follow-up period. STUDY
DESIGN: A randomised, single-blind study design was used in a sample of 30 healthy 6-9 year old children with 60 carious primary molars without clinical or radiographic evidence of pulp degeneration.
METHODS: The pulpotomy agents were assigned as follows: Group 1 was 1:5 diluted Buckley's formocresol (FC) and Group 2 was ABS. Clinical and radiographic follow-up at 3, 6, and 12 months used the following criteria: pain, swelling, sinus tract, mobility, internal root resorption, and furcation and/or periapical bone destruction. STATISTICS: The data were analysed using Chi-square tests.
RESULTS: The clinical and radiographic evaluation at 3 months revealed total success rates of 100% in the FC and ABS groups. Success rates in FC and ABS groups at 6 months were 96.7% and 93.3% respectively. At the 12-month follow-ups, the total success rates in the FC, and ABS groups were 89.3% and 85.7%, respectively. When the groups were compared according to the time intervals, no significant differences were observed between the 3, 6, and 12 month values. The success rates of the materials decreased over time.
CONCLUSIONS: FC and ABS were found successful as pulp dressings in primary molars. ABS appears to be an alternative pulpotomy agent but periodical follow-ups must be considered to evaluate long term success rates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22883359     DOI: 10.1007/bf03262870

Source DB:  PubMed          Journal:  Eur Arch Paediatr Dent        ISSN: 1818-6300


  26 in total

1.  Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.

Authors:  H Goker; I C Haznedaroglu; S Ercetin; S Kirazli; U Akman; Y Ozturk; H C Firat
Journal:  J Int Med Res       Date:  2008 Jan-Feb       Impact factor: 1.671

Review 2.  Durability of amalgam in the restoration of class II cavities in primary molars: a systematic review of the literature.

Authors:  N M Kilpatrick; A Neumann
Journal:  Eur Arch Paediatr Dent       Date:  2007-03

3.  Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp.

Authors:  H D Rodd; F M Boissonade
Journal:  Int J Paediatr Dent       Date:  2006-01       Impact factor: 3.455

Review 4.  Persuasive evidence that formocresol use in pediatric dentistry is safe.

Authors:  Alan R Milnes
Journal:  J Can Dent Assoc       Date:  2006-04       Impact factor: 1.316

Review 5.  Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis.

Authors:  Li Peng; Ling Ye; Hong Tan; Xuedong Zhou
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-09-26

6.  Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up.

Authors:  A B Fuks; G Holan; J M Davis; E Eidelman
Journal:  Pediatr Dent       Date:  1997 Jul-Aug       Impact factor: 1.874

7.  A new haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars.

Authors:  M E Odabaş; C Cinar; O Tulunoğlu; B Işik
Journal:  Pediatr Dent       Date:  2011 Nov-Dec       Impact factor: 1.874

8.  The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.

Authors:  A B S Moretti; V T Sakai; T M Oliveira; A P C Fornetti; C F Santos; M A A M Machado; R C C Abdo
Journal:  Int Endod J       Date:  2008-05-12       Impact factor: 5.264

9.  A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up.

Authors:  Deniz Sonmez; Saziye Sari; Tuğba Cetinbaş
Journal:  J Endod       Date:  2008-08       Impact factor: 4.171

Review 10.  Pulpotomy in primary teeth: review of the literature according to standardized criteria.

Authors:  A B Fuks; L Papagiannoulis
Journal:  Eur Arch Paediatr Dent       Date:  2006-06
View more
  8 in total

Review 1.  Does the use of natural products for endodontic therapy in primary teeth have sufficient evidence for clinical practice? A scoping review.

Authors:  Filipe Colombo Vitali; Ana Cristina Andrada; Helhen Cristina da Luz Cardoso; Gesner Francisco Xavier-Junior; Cleonice da Silveira Teixeira; Loise Pedrosa Salles; Erica Negrini Lia; Carla Massignan
Journal:  Clin Oral Investig       Date:  2022-07-19       Impact factor: 3.606

2.  Clinical and Radiographic Evaluation of Aloe vera vs Formocresol as a Pulpotomy Medicament in Primary Molars: A Double Blinded Randomized Controlled Trial.

Authors:  Divya Subramanyam; Sujatha Somasundaram
Journal:  Int J Clin Pediatr Dent       Date:  2020 Mar-Apr

3.  Correlation between International Normalized Ratio values and sufficiency of two different local hemostatic measures in anticoagulated patients.

Authors:  Mohamed Zaghlool Amer; Samah I Mourad; Ahmed S Salem; Ehab Abdelfadil
Journal:  Eur J Dent       Date:  2014-10

Review 4.  Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.

Authors:  Cem Simsek; Sebnem Selek; Meltem Koca; Ibrahim Celal Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-07-27

5.  Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines.

Authors:  Seyhan Turk; Umit Yavuz Malkan; Mehdi Ghasemi; Helin Hocaoglu; Duygu Mutlu; Gursel Gunes; Salih Aksu; Ibrahim Celalettin Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-02-10

6.  Evaluation of formocresol, calcium hydroxide, ferric sulfate, and MTA primary molar pulpotomies.

Authors:  Esma Yildiz; Gul Tosun
Journal:  Eur J Dent       Date:  2014-04

7.  Comparative Evaluation of Fresh Aloe barbadensis Plant Extract and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars: A 12-month Follow-up Study.

Authors:  Mehak Kalra; Nishita Garg; Mandeep Rallan; Lumbini Pathivada; Ramakrishna Yeluri
Journal:  Contemp Clin Dent       Date:  2017 Jan-Mar

Review 8.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.